Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists
Management

CEO: Sunil Bodapati (12/31/2019)
Technology: Aaron Mayer (12/31/2019)
Board

Company

Business description: At Enable Medicine, we index biological data into highly detailed maps of human disease. This atlas is utilized to guide novel drug target discovery, identify biomarkers of therapeutic response, and develop optimal treatment strategies. Our lab in Menlo Park, California, generates high-parameter biological datasets, and our cloud-based operating system allows researchers to organize, process, query, and analyze this data at scale. Taken together, our platform unlocks the ability to search biology, where complex questions about human disease can be asked and answered for the first time. We build and provide these capabilities to our network of leading academic institutions and pharmaceutical companies around the world. Our collaborative research spans numerous indications, with a core focus on unmet needs in oncology and autoimmune diseases. We advance science by accelerating data generation, methods development, research insights, and high-impact publications. Our interdisciplinary team of scientists, engineers, researchers, and investors focuses on decoding biological systems to make drug discovery, development, and patient care more deterministic.
Capital

Rounds: 2
Recent Fundings: Apr 2022   Aug 2020
Capital raised: 63.62M
Last Round: 60.0M
Ownership: Private  
VCs include: General Catalyst Partners Anthos CapitalInitialized CapitalBreyer Capital;  Axial VC;  Presight Capital

Last Tweets


 

Last Mentions


Overview
Record updated: Apr 2022
Sector: Biotech
Year Founded: 2019
Headcount: 11-25 as of Apr 2022
Rounds: 2
Recent Fundings: Apr 2022   Aug 2020
Capital Raised: 63.62M
Last Round: 60.0M
Ownership: Private